Home / Caspase-6 / Caspase-6 Inhibitor Z-VEID-FMK

Caspase-6 Inhibitor Z-VEID-FMK

Catalog #: FMK006
19 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
FMK006
Product Details
Citations (19)
FAQs
Reviews
Summary Product Datasheets Background

Caspase-6 Inhibitor Z-VEID-FMK Summary

 

Key Benefits

Cell permeable fluoromethyl ketone (FMK)-derivatized peptides act as effective irreversible Caspase inhibitors with no cytotoxic effects and, therefore, are useful tools for studying Caspase activity.

Specifications

Source
N/A
Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Species
Multi-Species

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Background: Caspase-6

Caspases are a family of cytosolic aspartate-specific cysteine proteases involved in the initiation and execution of apoptosis. They are expressed as latent zymogens and are activated by an autoproteolytic mechanism or by processing by other proteases (frequently other caspases). Human caspases can be subdivided into three functional groups: cytokine activation (caspase-1, -4, -5, and -13), apoptosis initiation (caspase-2, -8, -9, -and -10), and apoptosis execution (caspase-3, -6, and -7).

Caspases are regulated by a variety of stimili, including APAF1, CFLAR/FLIP, NOL3/ARC, and members of the inhibitor of apoptosis (IAP) family such as BIRC1/NAIP, BIRC2/cIAP-1, BIRC3/cIAP-2, BIRC4/XIAP, BIRC5/Survivin, and BIRC7/Livin. IAP activity is modulated by DIABLO/SMAC or PRSS25/HTRA2/Omi. Cell-permeable and irreversible peptide inhibitors are also available for different caspases.

Entrez Gene IDs
839 (Human); 12368 (Mouse); 83584 (Rat)
Alternate Names
Apoptotic protease Mch-2; CASP6; CASP-6; caspase 6, apoptosis-related cysteine peptidase; caspase 6, apoptosis-related cysteine protease; Caspase6; Caspase-6; EC 3.4.22; Mch2; MCH2EC 3.4.22.59

Citations for Caspase-6 Inhibitor Z-VEID-FMK

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

19 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Coronaviruses exploit a host cysteine-aspartic protease for replication
    Authors: H Chu, Y Hou, D Yang, L Wen, H Shuai, C Yoon, J Shi, Y Chai, TT Yuen, B Hu, C Li, X Zhao, Y Wang, X Huang, KS Lee, L Cuiting, JP Cai, VK Poon, CC Chan, AJ Zhang, S Yuan, KY Sit, DC Foo, WK Au, KK Wong, J Zhou, KH Kok, DY Jin, JF Chan, KY Yuen
    Nature, 2022-08-03;0(0):.  2022-08-03
  2. The caspase-6-p62 axis modulates p62 droplets based autophagy in a dominant-negative manner
    Authors: E Valionyte, Y Yang, SA Griffiths, AT Bone, ER Barrow, V Sharma, B Lu, S Luo
    Cell Death and Differentiation, 2021-12-03;0(0):.  2021-12-03
  3. Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid beta-Protein-Induced Synapse Loss in Alzheimer's Disease
    Authors: G Park, HS Nhan, SH Tyan, Y Kawakatsu, C Zhang, M Navarro, EH Koo
    Cell Rep, 2020-06-30;31(13):107839.  2020-06-30
  4. Osteogenic impact of pro-apoptotic caspase inhibitors in MC3T3-E1 cells
    Authors: A Kratochvíl, B Veselá, V Ledvina, E Švandová, K Klepárník, K Dadáková, P Beneš, E Matalová
    Sci Rep, 2020-05-04;10(1):7489.  2020-05-04
  5. The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
    Authors: AS Qadir, AM Stults, AE Murmann, ME Peter
    Sci Rep, 2020-01-28;10(1):1310.  2020-01-28
  6. Bacterial Pore-Forming Toxins Promote the Activation of Caspases in Parallel to Necroptosis to Enhance Alarmin Release and Inflammation During Pneumonia
    Authors: N Gonzalez-J, KM Bradley, AN Riegler, LF Reyes, T Brissac, SS Park, MI Restrepo, CJ Orihuela
    Sci Rep, 2018-04-11;8(1):5846.  2018-04-11
  7. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation
    Authors: K Harhouri, C Navarro, D Depetris, MG Mattei, X Nissan, P Cau, A De Sandre-, N Lévy
    EMBO Mol Med, 2017-09-01;0(0):.  2017-09-01
  8. Gene Expression Profiling of Cutaneous Injured and Non-Injured Nociceptors in SNI Animal Model of Neuropathic Pain
    Authors: T Berta, FE Perrin, M Pertin, R Tonello, YC Liu, A Chamessian, AC Kato, RR Ji, I Decosterd
    Sci Rep, 2017-08-24;7(1):9367.  2017-08-24
  9. Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia.
    Authors: Gonzalez-Juarbe N, Gilley R, Hinojosa C, Bradley K, Kamei A, Gao G, Dube P, Bergman M, Orihuela C
    PLoS Pathog, 2015-12-11;11(12):e1005337.  2015-12-11
  10. Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-alpha secretion.
    Authors: Berta T, Park C, Xu Z, Xie R, Liu T, Lu N, Liu Y, Ji R
    J Clin Invest, 2014-02-17;124(3):1173-86.  2014-02-17
  11. Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.
    Authors: El-Khoury V, Pierson S, Szwarcbart E, Brons N, Roland O, Cherrier-De Wilde S, Plawny L, Van Dyck E, Berchem G
    Leukemia, 2014-01-14;28(8):1636-46.  2014-01-14
  12. NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration.
    Authors: Magnifico S, Saias L, Deleglise B, Duplus E, Kilinc D, Miquel M, Viovy J, Brugg B, Peyrin J
    FASEB J, 2013-08-23;27(12):4712-22.  2013-08-23
  13. Axonal degeneration is regulated by the apoptotic machinery or a NAD+-sensitive pathway in insects and mammals.
    Authors: Schoenmann Z, Assa-Kunik E, Tiomny S, Minis A, Haklai-Topper L, Arama E, Yaron A
    J. Neurosci., 2010-05-05;30(18):6375-86.  2010-05-05
  14. Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop.
    Authors: Lee SC, Chan J, Clement MV, Pervaiz S
    Proteomics, 2006-04-01;6(8):2386-94.  2006-04-01
  15. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases.
    Authors: Conde de la Rosa L, Schoemaker MH, Vrenken TE, Buist-Homan M, Havinga R, Jansen PL, Moshage H
    J. Hepatol., 2005-09-12;44(5):918-29.  2005-09-12
  16. Increased sensitivity of early apoptotic cells to complement-mediated lysis.
    Authors: Attali G, Gancz D, Fishelson Z
    Eur. J. Immunol., 2004-11-01;34(11):3236-45.  2004-11-01
  17. Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor.
    Authors: Shah N, Asch RJ, Lysholm AS, Lebien TW
    Blood, 2004-07-08;104(9):2873-8.  2004-07-08
  18. NuMA and nuclear lamins behave differently in Fas-mediated apoptosis.
    Authors: Taimen P, Kallajoki M
    J. Cell. Sci., 2003-02-01;116(0):571-83.  2003-02-01
  19. Apaf-1 is a mediator of E2F-1-induced apoptosis.
    Authors: Furukawa Y, Nishimura N, Furukawa Y, Satoh M, Endo H, Iwase S, Yamada H, Matsuda M, Kano Y, Nakamura M
    J. Biol. Chem., 2002-07-30;277(42):39760-8.  2002-07-30

FAQs

  1. Does R&D Systems offer a negative control for Caspase Inihibitors with benzyloxycarbonyl group (Z-) at the N-terminus and the FMK functional group at the C-terminus?

    • Yes, R&D Systems offers Caspase Inhibitor Control Z-FA-FMK, Catalog # FMKC01, which is an inhibitor of cathepsins B and L but not caspases, and has been used in several systems as a negative control for peptide inhibitors of caspases.

  2. Are R&D Systems Caspase Inhibitors irreversible?

    • Yes, the majority of R&D Systems Caspase Inhibitors have a Fluoromethyl ketone (FMK) functional group on the C-terminus of the peptide, and act as effective irreversible inhibitors with no added cytotoxic effects. Inhibitors synthesized with a benzyloxycarbonyl group (also known as BOC or Z) at the N-terminus and O-methyl side chains exhibit enhanced cellular permeability.

      R&D Systems also offers a General Caspase Inhibitor, Q-VD-OPh, Catalog # OPH001, as well as a FITC-conjugated pan-caspase inhibitor (ApoStat), Catalog # FMK012, which are both cell-permeable, irreversible inhibitors of caspase activity.

View all Peptide FAQs

Reviews for Caspase-6 Inhibitor Z-VEID-FMK

There are currently no reviews for this product. Be the first to review Caspase-6 Inhibitor Z-VEID-FMK and earn rewards!

Have you used Caspase-6 Inhibitor Z-VEID-FMK?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review